XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
EXAGEN INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$7.43−0.29 (-3.76%)
Close on Oct 19, 2026
- Market cap
- $179.54M
- P/E (TTM)
- –
- Dividend yield
- –
Exagen statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | Exagen | Industry median |
|---|---|---|
| Market Cap | $179.99M | $1.11B |
| Enterprise Value | $178.25M | $1.41B |
| PS Ratio | 2.53 | 1.60 |
| PB Ratio | 14.73 | 3.03 |
| P/TBV Ratio | 14.73 | 4.99 |
Enterprise value
| Measure | Exagen | Industry median |
|---|---|---|
| EV / Sales | 2.51 | 1.69 |
Income (trailing twelve months)
| Measure | Exagen | Industry median |
|---|---|---|
| Revenue | $71.12M | $561.90M |
| Gross Profit | $41.70M | $173.32M |
| Operating Income | -$13.21M | -$1.81M |
| Net Income | -$18.92M | -$1.16M |
| EBITDA | -$10.81M | -$20.72K |
| EPS (Diluted) | -$0.81 | -$0.02 |
Margins
| Measure | Exagen | Industry median |
|---|---|---|
| Gross Margin | 58.6% | 33.1% |
| Operating Margin | -18.6% | -4.45% |
| Profit Margin | -26.6% | -2.91% |
| EBITDA Margin | -15.2% | 2.41% |
| FCF Margin | -10.7% | 3.13% |
Returns
| Measure | Exagen | Industry median |
|---|---|---|
| Return on Equity (ROE) | -113.8% | 1.84% |
| Return on Assets (ROA) | -34.2% | -3.06% |
| Return on Invested Capital (ROIC) | -86.1% | 2.11% |
| Return on Capital Employed (ROCE) | -34.3% | -0.57% |
Growth
| Measure | Exagen | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 20.8% | 6.92% |
| Revenue Growth (3Y CAGR) | 13.5% | 10.9% |
| Revenue Growth (5Y CAGR) | 9.66% | 13.2% |
Balance sheet
| Measure | Exagen | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $24.59M | $48.71M |
| Total Debt | $22.84M | $140.00M |
| Net Cash (Debt) | $1.75M | $205.49K |
| Net Cash Per Share | $0.07 | $0.01 |
| Equity (Book Value) | $12.22M | $235.16M |
| Book Value Per Share | $0.50 | $3.48 |
| Tangible Book Value | $12.22M | $703.69K |
| Working Capital | $29.40M | $30.48M |
Financial position
| Measure | Exagen | Industry median |
|---|---|---|
| Current Ratio | 3.18 | 1.40 |
| Quick Ratio | 2.75 | 1.02 |
| Debt / Equity | 1.87 | 0.66 |
| Interest Coverage | -2.58 | -0.63 |
Cash flow (trailing twelve months)
| Measure | Exagen | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.50M | $3.10M |
| Capital Expenditures | -$1.09M | -$18.62M |
| Free Cash Flow | -$7.59M | $23.73M |
| FCF Per Share | -$0.31 | $0.37 |
Efficiency
| Measure | Exagen | Industry median |
|---|---|---|
| Asset Turnover | 1.29 | 0.87 |
| Revenue Per Employee | $323.28K | $228.48K |
| Profits Per Employee | -$86.01K | -$5.75K |
| Employee Count | 220 | 910 |
Dividends and yields
| Measure | Exagen | Industry median |
|---|---|---|
| Earnings Yield | -10.5% | -0.59% |
| FCF Yield | -4.22% | 1.74% |
Shares
| Measure | Exagen | Industry median |
|---|---|---|
| Shares Outstanding | 24,225,300 | 58,282,400 |
| Shares Change (YoY) | 23.9% | 2.68% |
| Shares Change (QoQ) | 0.44% | 0.32% |
| Float | 19,534,800 | 33,780,100 |
| Shares Held by Insiders | 19.4% | 16.4% |
| Shares Held by Institutions | 34.1% | 85.9% |
Taxes
| Measure | Exagen | Industry median |
|---|---|---|
| Income Tax | $50.00K | $697.00K |
Scores
| Measure | Exagen | Industry median |
|---|---|---|
| Altman Z-Score | -4.74 | 2.05 |
| Piotroski F-Score | 4 | 5 |
| Beneish M-Score | -2.76 | -2.71 |
Calculated by StockData from Exagen's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.